Literature DB >> 1222751

Paradoxical intoxication--a complication of anticonvulsant administration.

A S Troupin, L M Ojemann.   

Abstract

A new syndrome, paradoxical intoxication, has been defined in which high levels of hydantoins, and in one instance carbamazepine, produced an increase in seizures with little or no evidence of intoxication; a decrease in these levels produced an improvement in seizure control. This syndrome occurs often but not exclusively in those people who are less astute in assessing their neurologic status and therefore may experience unexpectedly higher blood levels of their anticonvulsants. Instances have been documented with serum levels above 40 mugm/ml for phenytoin or mephenytoin alone, or above 50 mugm/ml of combined hydantoins phenytoin and mephenytoin, and when the level is in the range of 20 mugm/ml and above for carbamazepine. Possible mechanisms underlying the syndrome are reviewed. Appropriate therapy is a reduction of the dose of the drug in question.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1222751     DOI: 10.1111/j.1528-1157.1975.tb04761.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  19 in total

Review 1.  Therapeutic drug monitoring of phenytoin. Rationale and current status.

Authors:  M Levine; T Chang
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Dose-related adverse effects of anticonvulsants.

Authors:  A S Troupin
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

Review 3.  Effects of psychotropic drugs on seizure threshold.

Authors:  Francesco Pisani; Giancarla Oteri; Cinzia Costa; Giorgio Di Raimondo; Raoul Di Perri
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 4.  Clinical features and management of poisoning due to phenytoin.

Authors:  J R Larsen; L S Larsen
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

Review 5.  Adverse neuropsychiatric effects of anticonvulsant drugs.

Authors:  E H Reynolds; M R Trimble
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients.

Authors:  Ramasamy Kesavan; Sunil K Narayan; Chandrasekaran Adithan
Journal:  Eur J Clin Pharmacol       Date:  2010-07       Impact factor: 2.953

7.  Manic state with carbamazepine therapy of seizures.

Authors:  M E Drake; W T Peruzzi
Journal:  J Natl Med Assoc       Date:  1986-11       Impact factor: 1.798

Review 8.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 9.  Phenytoin versus valproate monotherapy for partial onset seizures and generalised onset tonic-clonic seizures: an individual participant data review.

Authors:  Sarah J Nolan; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-04-28

10.  Carbamazepine as a single drug in the treatment of epilepsy. A prospective study of serum levels and seizure control.

Authors:  N Callaghan; M O'Callaghan; B Duggan; M Feely
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.